{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:02:34Z","timestamp":1794110554890,"version":"4.8.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00238538"],"award-info":[{"award-number":["RS-2023-00238538"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117515","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:59:55Z","timestamp":1727830795000},"page":"117515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Modulation of chemotherapy-induced peripheral neuropathy by JZL195 through glia and the endocannabinoid system"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8695-7764","authenticated-orcid":false,"given":"Leejeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8238-6899","authenticated-orcid":false,"given":"Guanghai","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7993-672X","authenticated-orcid":false,"given":"Myeounghoon","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bae Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.117515_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/j.pain.0000000000001540","article-title":"Chemotherapy-induced peripheral neuropathy: where are we now?","volume":"160 Suppl 1","author":"Colvin","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.117515_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2024.117515_bib3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117515_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment","volume":"9","author":"Burgess","year":"2021","journal-title":"Oncol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2024.117515_bib5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrneurol.2014.211","article-title":"Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain","volume":"10","author":"Sisignano","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2024.117515_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.12.006","article-title":"a.l. et, Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy","volume":"73","author":"Lees","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2024.117515_bib7","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1007\/s10072-021-05576-6","article-title":"Chemotherapy and peripheral neuropathy","volume":"42","author":"Li","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.biopha.2024.117515_bib8","article-title":"Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy","volume":"11","author":"Fumagalli","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.117515_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuro.2022.09.006","article-title":"Emerging roles of toll-like receptor 4 in chemotherapy-induced neurotoxicity","volume":"93","author":"Oo","year":"2022","journal-title":"Neurotoxicology"},{"issue":"10","key":"10.1016\/j.biopha.2024.117515_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopsych.2017.06.032","article-title":"Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence","volume":"84","author":"Slivicki","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2024.117515_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108555","article-title":"The cannabinoid system and microglia in health and disease","volume":"190","author":"Duffy","year":"2021","journal-title":"Neuropharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.117515_bib12","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"issue":"19","key":"10.1016\/j.biopha.2024.117515_bib13","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1111\/bph.15208","article-title":"Cannabinoid control of neurogenic inflammation","volume":"177","author":"McKenna","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117515_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2017.06.015","article-title":"The cannabinoid system and pain","volume":"124","author":"Woodhams","year":"2017","journal-title":"Neuropharmacology"},{"issue":"6604","key":"10.1016\/j.biopha.2024.117515_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.biopha.2024.117515_bib16","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117515_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108712","article-title":"Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: possible role of CB1 and TRPV1 receptors","volume":"197","author":"Silva-Cardoso","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2024.117515_bib18","doi-asserted-by":"crossref","first-page":"1061220","DOI":"10.3389\/fnmol.2023.1061220","article-title":"Spinal cannabinoid receptor 2 activation alleviates neuropathic pain by regulating microglia and suppressing P2X7 receptor","volume":"16","author":"Zhou","year":"2023","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.117515_bib19","first-page":"1260353","article-title":"Antiallodynic effects of cannabinoid receptor 2 (CB(2)R) agonists on retrovirus infection-induced neuropathic pain","author":"Sheng","year":"2019","journal-title":"Pain. Res. Manag"},{"issue":"12","key":"10.1016\/j.biopha.2024.117515_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1850","article-title":"a.l. et, Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain","volume":"10","author":"Wilkerson","year":"2020","journal-title":"Brain Behav."},{"issue":"48","key":"10.1016\/j.biopha.2024.117515_bib21","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bph.13337","article-title":"Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine neuropathic pain model","volume":"173","author":"Adamson Barnes","year":"2016","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117515_bib23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2013.12.018","article-title":"Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine inflammatory pain model","volume":"81","author":"Anderson","year":"2014","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.biopha.2024.117515_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6312","key":"10.1016\/j.biopha.2024.117515_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2024.117515_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/j.1532-2149.2012.00219.x","article-title":"The contribution of satellite glial cells to chemotherapy-induced neuropathic pain","volume":"17","author":"Warwick","year":"2013","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.biopha.2024.117515_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2014.06.016","article-title":"Glial role in oxaliplatin-induced neuropathic pain","volume":"261","author":"Di Cesare Mannelli","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2024.117515_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642420","article-title":"Neuroimmune consequences of eIF4E phosphorylation on chemotherapy-induced peripheral neuropathy","volume":"12","author":"Agalave","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170814","article-title":"Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy","volume":"12","author":"Makker","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2024.117515_bib30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0021-9258(17)49922-4","article-title":"Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy","volume":"295","author":"Wang","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2024.117515_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","article-title":"Astrocytes in chronic pain and itch","volume":"20","author":"Ji","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2024.117515_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.biopha.2024.117515_bib33","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1097\/j.pain.0000000000000982","article-title":"Spinal microglia are required for long-term maintenance of neuropathic pain","volume":"158","author":"Echeverry","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.117515_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbi.2017.10.011","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) dependent microglial activation promotes cisplatin-induced peripheral neuropathy in mice","volume":"68","author":"Hu","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2024.117515_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113695","article-title":"Cisplatin-induced activation and functional modulation of satellite glial cells lead to cytokine-mediated modulation of sensory neuron excitability","volume":"341","author":"Leo","year":"2021","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117515_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.819","article-title":"Analgesic effects of medicinal plants and phytochemicals on chemotherapy-induced neuropathic pain through glial modulation","volume":"9","author":"Lee","year":"2021","journal-title":"Pharm. Res Perspect."},{"issue":"11","key":"10.1016\/j.biopha.2024.117515_bib37","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11912-023-01449-7","article-title":"Chemotherapy-induced peripheral neuropathy: diagnosis, agents, general clinical presentation, and treatments","volume":"25","author":"Molinares","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.biopha.2024.117515_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbi.2022.02.016","article-title":"Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases","volume":"102","author":"Acioglu","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.biopha.2024.117515_bib39","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/j.pain.0000000000001306","article-title":"a.l. et, Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states","volume":"159","author":"Bruno","year":"2018","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.biopha.2024.117515_bib40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cmdc.201500188","article-title":"Therapeutic developments targeting toll-like receptor-4-mediated neuroinflammation","volume":"11","author":"Li","year":"2016","journal-title":"Chem. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-4159.2010.06736.x","article-title":"Toll-like receptor 4 in CNS pathologies","volume":"114","author":"Buchanan","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2024.117515_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918807050","article-title":"TLR4\/NF-\u03baB signaling activation in plantar tissue and dorsal root ganglion involves in the development of postoperative pain","volume":"14","author":"Xing","year":"2018","journal-title":"Mol. Pain."},{"key":"10.1016\/j.biopha.2024.117515_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/JPR.S241101","article-title":"Electroacupuncture treatment attenuates paclitaxel-induced neuropathic pain in rats via inhibiting spinal glia and the TLR4\/NF-\u03baB pathway","volume":"13","author":"Zhao","year":"2020","journal-title":"J. Pain. Res."},{"issue":"23","key":"10.1016\/j.biopha.2024.117515_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235917","article-title":"Electroacupuncture alleviates paclitaxel-induced peripheral neuropathic pain in rats via suppressing TLR4 signaling and TRPV1 upregulation in sensory neurons","volume":"20","author":"Li","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.117515_bib45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jpp\/rgad023","article-title":"a.l. et, Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation","volume":"75","author":"Dos Santos","year":"2023","journal-title":"J. Pharm. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13041-022-00960-5","article-title":"Toll-like receptors and their role in neuropathic pain and migraine","volume":"15","author":"Liu","year":"2022","journal-title":"Mol. Brain"},{"issue":"7","key":"10.1016\/j.biopha.2024.117515_bib47","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpain.2014.04.001","article-title":"Toll-like receptor 4 signaling contributes to paclitaxel-induced peripheral neuropathy","volume":"15","author":"Li","year":"2014","journal-title":"J. Pain."},{"issue":"7","key":"10.1016\/j.biopha.2024.117515_bib48","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202059","article-title":"Normalization of cholesterol metabolism in spinal microglia alleviates neuropathic pain","volume":"218","author":"Navia-Pelaez","year":"2021","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.117515_bib49","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1097\/j.pain.0000000000002834","article-title":"AIBP regulates TRPV1 activation in chemotherapy-induced peripheral neuropathy by controlling lipid raft dynamics and proximity to TLR4 in dorsal root ganglion neurons","volume":"164","author":"Navia-Pelaez","year":"2023","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.biopha.2024.117515_bib50","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.celrep.2018.04.110","article-title":"Inhibition of neuroinflammation by AIBP: spinal effects upon facilitated pain states","volume":"23","author":"Woller","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2024.117515_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jpsychires.2019.10.010","article-title":"Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats","volume":"120","author":"Dong","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.biopha.2024.117515_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pbb.2014.05.022","article-title":"The dual FAAH\/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184","volume":"124","author":"Seillier","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.biopha.2024.117515_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108919","article-title":"Inhibition of cannabinoid degradation enhances hippocampal contextual fear memory and exhibits anxiolytic effects","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"issue":"19","key":"10.1016\/j.biopha.2024.117515_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911571","article-title":"Crotalphine modulates microglia M1\/M2 phenotypes and induces spinal analgesia mediated by opioid-cannabinoid systems","volume":"23","author":"Lopes","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117515_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainresbull.2018.02.003","article-title":"Antinociceptive effects of the endogenous cannabinoid peptide agonist VD-hemopressin(\u03b2) in mice","volume":"139","author":"Wang","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.biopha.2024.117515_bib56","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/ALN.0000000000000422","article-title":"Cannabinoid receptor type 1 antagonist, AM251, attenuates mechanical allodynia and thermal hyperalgesia after burn injury","volume":"121","author":"Ueda","year":"2014","journal-title":"Anesthesiology"},{"issue":"1-3","key":"10.1016\/j.biopha.2024.117515_bib57","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pain.2006.07.008","article-title":"Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence","volume":"126","author":"Trang","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.117515_bib58","unstructured":"S. Chaplan, J. Pogrel, T. Yaksh, Pharmacologic modulation of tactile allodynia in a rat neuropathy model, 7th World Congress on Pain (IASP) meeting, Paris, 1993."},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"issue":"10","key":"10.1016\/j.biopha.2024.117515_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102543","article-title":"Dual inhibition of FAAH and MAGL counteracts migraine-like pain and behavior in an animal model of migraine","volume":"10","author":"Greco","year":"2021","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.biopha.2024.117515_bib61","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s40265-021-01579-x","article-title":"Cannabinoid formulations and delivery systems: current and future options to treat pain","volume":"81","author":"Stella","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phrs.2012.10.013","volume":"67","author":"Guindon","year":"2013","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.117515_bib63","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/j.pain.0000000000002454","article-title":"Dorsal root ganglion toll-like receptor 4 signaling contributes to oxaliplatin-induced peripheral neuropathy","volume":"163","author":"Illias","year":"2022","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.biopha.2024.117515_bib64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jpain.2018.10.007","article-title":"Cannabinoid type 2 receptor system modulates paclitaxel-induced microglial dysregulation and central sensitization in rats","volume":"20","author":"Wu","year":"2019","journal-title":"J. Pain."},{"issue":"5","key":"10.1016\/j.biopha.2024.117515_bib65","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1213\/ANE.0b013e31824b0191","article-title":"Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system","volume":"114","author":"Naguib","year":"2012","journal-title":"Anesth. Analg."},{"issue":"12","key":"10.1016\/j.biopha.2024.117515_bib66","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1523\/JNEUROSCI.4071-08.2009","article-title":"Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury","volume":"29","author":"Lever","year":"2009","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2024.117515_bib67","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.pain.2012.02.015","article-title":"Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels","volume":"153","author":"Wilkerson","year":"2012","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.biopha.2024.117515_bib68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MOL.0b013e32803dbdec","article-title":"Endocannabinoids and the regulation of their levels in health and disease","volume":"18","author":"Di Marzo","year":"2007","journal-title":"Curr. Opin. Lipido"},{"issue":"6","key":"10.1016\/j.biopha.2024.117515_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101999","article-title":"Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain","volume":"298","author":"Ghosh","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117515_bib70","article-title":"Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.117515_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.747229","article-title":"Quality of life and a surveillant endocannabinoid system","volume":"15","author":"de Melo Reis","year":"2021","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2024.117515_bib72","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.2147\/JPR.S281190","article-title":"Vagus nerve stimulation transiently mitigates chemotherapy-induced peripheral neuropathy in rats","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Pain. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12964-023-01100-9","article-title":"Promoting AMPK\/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy","volume":"21","author":"Yang","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"4","key":"10.1016\/j.biopha.2024.117515_bib74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12272-019-01137-w","article-title":"Differential effect of LPS and paclitaxel on microglial functional phenotypes and circulating cytokines: the possible role of CX3CR1 and IL-4\/10 in blocking persistent inflammation","volume":"42","author":"Ha","year":"2019","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.biopha.2024.117515_bib75","article-title":"TMI-1, TNF-\u03b1-converting enzyme inhibitor, protects against paclitaxel-induced neurotoxicity in the DRG neuronal cells In Vitro","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.117515_bib76","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/j.pain.0000000000001831","article-title":"Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy","volume":"161","author":"Chen","year":"2020","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.biopha.2024.117515_bib77","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tips.2022.05.004","article-title":"Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions","volume":"43","author":"Squillace","year":"2022","journal-title":"Trends Pharm. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.117515_bib78","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jpain.2016.02.011","article-title":"a.l. et, Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy-induced peripheral neuropathy","volume":"17","author":"Zhang","year":"2016","journal-title":"J. Pain."},{"issue":"5","key":"10.1016\/j.biopha.2024.117515_bib79","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jpp\/rgad023","article-title":"Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation","volume":"75","author":"Dos Santos","year":"2023","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2024.117515_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1303937","article-title":"Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation","volume":"15","author":"Moraes","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117515_bib81","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbi.2015.06.003","article-title":"MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy","volume":"49","author":"Li","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.biopha.2024.117515_bib82","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117515_bib83","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s12640-021-00442-x","article-title":"Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors","volume":"39","author":"Pereira","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2024.117515_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110456","article-title":"Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain","volume":"129","author":"Thomas","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.117515_bib85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1744-8069-8-71","article-title":"The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB\u2082 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy","volume":"8","author":"Deng","year":"2012","journal-title":"Mol. Pain."},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib86","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41398-018-0141-7","article-title":"Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors","volume":"8","author":"Bedse","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2024.117515_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111522","article-title":"Lipid endocannabinoids in energy metabolism, stress and developmental programming","volume":"542","author":"Almeida","year":"2022","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.biopha.2024.117515_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110116","article-title":"The endocannabinoid system in the amygdala and modulation of fear","volume":"105","author":"Gunduz-Cinar","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib89","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bcpt.13876","article-title":"a.l. et, Cannabidiol reduces lipopolysaccharide-induced nociception via endocannabinoid system activation","volume":"133","author":"Dos Santos","year":"2023","journal-title":"Basic Clin. Pharm. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117515_bib90","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12974-017-0913-7","article-title":"Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity","volume":"14","author":"Sun","year":"2017","journal-title":"J. Neuroinflamm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401401X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401401X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:08:49Z","timestamp":1773968929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222401401X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":90,"alternative-id":["S075333222401401X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117515","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of chemotherapy-induced peripheral neuropathy by JZL195 through glia and the endocannabinoid system","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117515"}}